© 2026 WUKY
background_fid.jpg
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Sen. Rand Paul announces COVID 'whistleblower' testimony in committee this week

Sen. Rand Paul, R-Ky., listens to a response as he questions Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, during a Senate Health, Education, Labor, and Pensions Committee hearing on Capitol Hill, Thursday, Nov. 4, 2021, in Washington. (AP Photo/Alex Brandon)
Alex Brandon/AP
/
AP
Sen. Rand Paul, R-Ky., listens to a response as he questions Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, during a Senate Health, Education, Labor, and Pensions Committee hearing on Capitol Hill, Thursday, Nov. 4, 2021, in Washington. (AP Photo/Alex Brandon)

Kentucky U.S. Sen. Rand Paul is convening a hearing Wednesday to receive whistleblower testimony related to the COVID-19 pandemic.

Last week, Paul had revived his push to indict former White House chief medical advisor Anthony Fauci over claims that the health expert lied under oath about funding research involving bat coronaviruses in Wuhan, China. That was ahead of a Monday deadline when the statute of limitations would take effect.

With that date now hit and no action taken, the senator says he'll be hearing whistleblower testimony in the Senate Homeland Security committee. In a release, Paul's office says the testimony will "expose the cover-up over the origins of COVID-19 and the lack of transparency from the federal government."

Paul has been adamant that the pandemic policies guided by Fauci were a mistake the country shouldn't repeat.

"This isn't just looking back in the rearview mirror just for the hell of it," Paul said. "This is to make sure we actually learn something and don't do this kind of lockdown mentality again."

While Paul's renewed focus comes after one of Fauci's former advisors, David Morens, was indicted on charges of concealing and destroying information, Fauci has repeatedly denied making any false statements to Congress and disputed Paul's characterization of the research in question.